… response known as “cytokine storm”. This phenomenon … the sustained release of cytokines,
implementing therapeutics that … with the cytokine storm, such as IL-1 inhibitors, IL-6 inhibitors, …

… , and immunotherapies (8–10). Under the normal physiological state, the levels of pro-inflammatory …
Moreover, it is also recommended as a therapeutic option in patients who have …

… In cytokine storm syndromes, the subcutaneous route is often … in the management of cytokine
storm syndromes and review the … improve the poor prognosis of cytokine storm syndromes. …

… up to 2 weeks after the infusion of immunotherapies directed against malignant B cells. This
… many new options for testing and treatment that, if wielded wisely, may quell the storm and …

… Among the available therapeutic options in India, we attempted to summarize the therapies
… antigen receptor T-cell (CART) immunotherapy. However, the use of tocilizumab cause even …

… cytokine storm was first used in 2010 to describe the side effects of chimeric antigen receptor
T-cell immunotherapy … has highlighted potential clinical treatment options for cytokine storm-…

… immunotherapy as an attractive option to fight SARS-CoV-2 [Citation7–Citation9]. In this
paper, an overview of the immunotherapy … cytokine neutralization that prevents cytokine storm, …

… Clinical studies have identified a cytokine storm in the third … towards the invaded viruses in
a cytokine storm is a critical step to … all therapeutic mAbs targeting cytokine storm, which are in …

… Cytokine storm was previously known as an influenza type syndrome occurring after the
systemic infection including sepsis and after immunotherapy … cytokines leading to cytokine storm …

… cytokines in patients with COVID-19, suggesting the existence of cytokine storm in some …
understanding about the recognition and potential therapeutic options of CSS in COVID-19. …